CIBC Private Wealth Group LLC Buys 5,589 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

CIBC Private Wealth Group LLC lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 27.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,627 shares of the medical device company’s stock after acquiring an additional 5,589 shares during the period. CIBC Private Wealth Group LLC’s holdings in Cooper Companies were worth $2,355,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Byrne Asset Management LLC bought a new position in Cooper Companies in the fourth quarter worth about $33,000. OFI Invest Asset Management purchased a new position in shares of Cooper Companies in the 4th quarter worth approximately $34,000. New Age Alpha Advisors LLC bought a new position in shares of Cooper Companies during the 4th quarter worth approximately $38,000. West Financial Advisors LLC purchased a new stake in Cooper Companies during the fourth quarter valued at approximately $49,000. Finally, Atala Financial Inc acquired a new stake in Cooper Companies in the fourth quarter valued at approximately $51,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

COO has been the subject of several analyst reports. Stifel Nicolaus decreased their price objective on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Finally, Morgan Stanley dropped their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $81.23 on Thursday. The company has a 50 day simple moving average of $88.59 and a two-hundred day simple moving average of $96.72. The stock has a market cap of $16.24 billion, a price-to-earnings ratio of 41.66, a PEG ratio of 2.25 and a beta of 1.02. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 12 month low of $77.05 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.